- Home
- BLIN vs NCNA Comparison
BLIN vs NCNA Comparison
Compare BLIN & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLIN | NCNA |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 13.8M |
| IPO Year | 2007 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BLIN | NCNA |
|---|---|---|
| Price | $0.87 | $3.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.62 | N/A |
| AVG Volume (30 Days) | 81.1K | ★ 83.4K |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,383,000.00 | N/A |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $21.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.16 | N/A |
| 52 Week Low | $0.69 | $2.78 |
| 52 Week High | $2.22 | $268.00 |
Technical Indicators
Market Signals| Indicator | BLIN | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 38.59 |
| Support Level | $0.82 | $3.14 |
| Resistance Level | $0.88 | $3.50 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 51.20 | 9.70 |
Price Performance
Historical ComparisonAbout BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.